Arvinas (@arvinasinc) 's Twitter Profile
Arvinas

@arvinasinc

A revolutionary approach to protein degradation therapeutics.
arvinas.com/ArvinasCG

ID: 831197090168598530

linkhttp://www.arvinas.com calendar_today13-02-2017 17:43:23

1,1K Tweet

3,3K Followers

275 Following

Arvinas (@arvinasinc) 's Twitter Profile Photo

#DYK Parkinson’s disease is the second most common neurodegenerative disorder? April is #Parkinsons Awareness Month – an important reminder to educate ourselves about symptoms, risk factors, and the impact Parkinson’s has on patients and families. #ParkinsonsAwareness

Arvinas (@arvinasinc) 's Twitter Profile Photo

#NEWS: Arvinas Announces Results from the PROTAC Estrogen Receptor Degrader Phase 3 Trial Selected as Late-Breaking Oral Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting Learn More: bit.ly/3Gh0zn4

#NEWS: Arvinas Announces Results from the PROTAC Estrogen Receptor Degrader Phase 3 Trial Selected as Late-Breaking Oral Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Learn More: bit.ly/3Gh0zn4
Arvinas (@arvinasinc) 's Twitter Profile Photo

#NEWS: Arvinas Shares New Preclinical Combination Data for their PROTAC BCL6 Degrader at the 2025 American Association for Cancer Research Annual Meeting. Learn More: bit.ly/3ECUUHs $ARVN

#NEWS: Arvinas Shares New Preclinical Combination Data for their PROTAC BCL6 Degrader at the 2025 American Association for Cancer Research Annual Meeting. Learn More: bit.ly/3ECUUHs
$ARVN
Arvinas (@arvinasinc) 's Twitter Profile Photo

#NEWS: Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025. Learn More: bit.ly/3Ym7EZz $ARVN

#NEWS: Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025. Learn More: bit.ly/3Ym7EZz
$ARVN
Arvinas (@arvinasinc) 's Twitter Profile Photo

We were honored to welcome Trish Michelle from the breasties to #Arvinas. Trish shared her personal experience with breast cancer and how it inspired her to advocate for others and help build a powerful community of support, education, and empowerment. Thank you, Trish, for

We were honored to welcome Trish Michelle from <a href="/The_Breasties/">the breasties</a> to #Arvinas. Trish shared her personal experience with breast cancer and how it inspired her to advocate for others and help build a powerful community of support, education, and empowerment. 

Thank you, Trish, for
Arvinas (@arvinasinc) 's Twitter Profile Photo

Today, we pause to remember and honor those who made the ultimate sacrifice serving our country. Their courage and dedication will never be forgotten. #MemorialDay

Today, we pause to remember and honor those who made the ultimate sacrifice serving our country. Their courage and dedication will never be forgotten. 

#MemorialDay
Arvinas (@arvinasinc) 's Twitter Profile Photo

We’re proud to join @Pfizer today at #ASCO25 for a late-breaking oral presentation sharing results from a Phase 3 clinical trial for patients with ER+/HER2- advanced #BreastCancer. These data were simultaneously published in NEJM. Learn more: bit.ly/45ARgst

Arvinas (@arvinasinc) 's Twitter Profile Photo

Today is #NationalCancerSurvivorsDay– a day to honor survivors and reaffirm the ongoing support they deserve. We recognize the critical need for expanded resources, continued research, and greater awareness to enhance quality of life during and after cancer treatment. Together,

Today is #NationalCancerSurvivorsDay– a day to honor survivors and reaffirm the ongoing support they deserve. We recognize the critical need for expanded resources, continued research, and greater awareness to enhance quality of life during and after cancer treatment. Together,
Arvinas (@arvinasinc) 's Twitter Profile Photo

Happy #PrideMonth! At Arvinas, we celebrate and support the LGBTQ+ community by fostering an environment of inclusion, authenticity, and belonging each and every day. We stand proudly with our LGBTQ+ colleagues, partners, and communities in the ongoing pursuit of equality and

Happy #PrideMonth! At Arvinas, we celebrate and support the LGBTQ+ community by fostering an environment of inclusion, authenticity, and belonging each and every day. 

We stand proudly with our LGBTQ+ colleagues, partners, and communities in the ongoing pursuit of equality and
Arvinas (@arvinasinc) 's Twitter Profile Photo

June is Alzheimer’s & Brain Awareness Month—a reminder that 7.2M+ Americans aged 65+ are living with Alzheimer’s. At Arvinas, our purpose drives our commitment to pioneering targeted protein degradation therapies for neurodegenerative diseases. #AlzheimersAwarenessMonth

June is Alzheimer’s &amp; Brain Awareness Month—a reminder that 7.2M+ Americans aged 65+ are living with Alzheimer’s. At Arvinas, our purpose drives our commitment to pioneering targeted protein degradation therapies for neurodegenerative diseases. 

#AlzheimersAwarenessMonth
Arvinas (@arvinasinc) 's Twitter Profile Photo

#NEWS: We’re pleased to announce our first ever New Drug Application submitted to the U.S. FDA with our partner at @Pfizer. The submission is based on a global, randomized Phase 3 trial for the potential treatment of ESR1-mutated ER+/HER2- advanced or metastatic #BreastCancer.

#NEWS: We’re pleased to announce our first ever New Drug Application submitted to the U.S. FDA with our partner at @Pfizer.

The submission is based on a global, randomized Phase 3 trial for the potential treatment of ESR1-mutated ER+/HER2- advanced or metastatic #BreastCancer.
Arvinas (@arvinasinc) 's Twitter Profile Photo

Earlier this month, #TeamArvinas gathered for our annual company picnic and it served as the perfect opportunity to take a break from busy days in the lab and at our desks. We are always grateful for the opportunity to connect with each other in meaningful ways. The team enjoyed

Earlier this month, #TeamArvinas gathered for our annual company picnic and it served as the perfect opportunity to take a break from busy days in the lab and at our desks. We are always grateful for the opportunity to connect with each other in meaningful ways. The team enjoyed
Arvinas (@arvinasinc) 's Twitter Profile Photo

Charlie leads Medical Writing, Data Management, & Clinical Operations, helping advance potential therapies from clinical candidate nomination through trial execution. His team drives timelines & budgets, while making sure our clinical trials are thoughtfully designed, rigorously

Charlie leads Medical Writing, Data Management, &amp; Clinical Operations, helping advance potential therapies from clinical candidate nomination through trial execution. His team drives timelines &amp; budgets, while making sure our clinical trials are thoughtfully designed, rigorously
Arvinas (@arvinasinc) 's Twitter Profile Photo

Happy Fourth of July! Today we’re celebrating innovation, collaboration, and independence. 🇺🇸 #IndependenceDay

Happy Fourth of July! Today we’re celebrating innovation, collaboration, and independence. 🇺🇸 
#IndependenceDay
Arvinas (@arvinasinc) 's Twitter Profile Photo

#ICYMI: Our CMO Dr. Noah Berkowitz shares his reflections from #ASCO25—highlighting advances in breast cancer care and our pioneering protein degradation therapies. #CancerResearch #Innovation linkedin.com/feed/update/ur…

Arvinas (@arvinasinc) 's Twitter Profile Photo

As pioneers in targeted protein degradation, we’re advancing our PROTAC Discovery Engine platform, which creates PROTACs that are designed to harness the cell’s natural disposal system to eliminate disease-causing proteins. That work requires not only breakthrough technology,

As pioneers in targeted protein degradation, we’re advancing our PROTAC Discovery Engine platform, which creates PROTACs that are designed to harness the cell’s natural disposal system to eliminate disease-causing proteins.

That work requires not only breakthrough technology,